Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 8 studies | 31% ± 12% | |
epithelial cell | 5 studies | 32% ± 10% | |
enterocyte | 4 studies | 20% ± 1% | |
intestinal crypt stem cell | 4 studies | 22% ± 2% | |
progenitor cell | 3 studies | 27% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 65% | 545.15 | 629 / 966 | 42% | 15.41 | 219 / 527 |
stomach | 1% | 0.03 | 2 / 359 | 31% | 10.13 | 88 / 286 |
breast | 30% | 10.07 | 138 / 459 | 0% | 0.01 | 2 / 1118 |
adipose | 29% | 8.63 | 349 / 1204 | 0% | 0 | 0 / 0 |
bladder | 5% | 0.29 | 1 / 21 | 18% | 6.80 | 93 / 504 |
spleen | 22% | 2.10 | 53 / 241 | 0% | 0 | 0 / 0 |
brain | 19% | 4.91 | 507 / 2642 | 0% | 0 | 0 / 705 |
peripheral blood | 15% | 2.07 | 140 / 929 | 0% | 0 | 0 / 0 |
kidney | 7% | 0.53 | 6 / 89 | 0% | 0.02 | 2 / 901 |
pancreas | 5% | 0.37 | 17 / 328 | 1% | 0.08 | 2 / 178 |
esophagus | 1% | 0.19 | 16 / 1445 | 4% | 0.16 | 8 / 183 |
lung | 2% | 0.15 | 10 / 578 | 1% | 0.25 | 14 / 1155 |
thymus | 1% | 0.08 | 8 / 653 | 0% | 0.36 | 2 / 605 |
skin | 1% | 0.11 | 20 / 1809 | 0% | 0 | 0 / 472 |
blood vessel | 1% | 0.09 | 13 / 1335 | 0% | 0 | 0 / 0 |
uterus | 0% | 0 | 0 / 170 | 1% | 0.17 | 4 / 459 |
adrenal gland | 0% | 0.03 | 1 / 258 | 0% | 1.03 | 1 / 230 |
prostate | 1% | 0.13 | 2 / 245 | 0% | 0 | 0 / 502 |
liver | 0% | 0 | 0 / 226 | 0% | 0.04 | 2 / 406 |
heart | 0% | 0.02 | 3 / 861 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0.02 | 1 / 430 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000255 | Biological process | allantoin metabolic process |
GO_0019628 | Biological process | urate catabolic process |
GO_0006144 | Biological process | purine nucleobase metabolic process |
GO_0008150 | Biological process | biological_process |
GO_0005575 | Cellular component | cellular_component |
GO_0005777 | Cellular component | peroxisome |
GO_0051997 | Molecular function | 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity |
GO_0016831 | Molecular function | carboxy-lyase activity |
Gene name | URAD |
Protein name | Putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (OHCU decarboxylase) (EC 4.1.1.97) (Parahox neighbor) (Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase) |
Synonyms | PRHOXNB |
Description | FUNCTION: Catalyzes the stereoselective decarboxylation of 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline (OHCU) to (S)-allantoin. . |
Accessions | A6NGE7 ENST00000332715.6 |